Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

For the new study, researchers set out to confirm that PROSTOX works in a new group of 148 patients who’d received stereotactic body radiotherapy (SBRT) for their prostate cancer. SBRT is a ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was ...

Prostate-specific antigen; SBRT: Stereotactic body radiation therapy. CTV = GTV + 3 mm anteriorly and laterally, 1 mm posteriorly PTV = CTV + 2 mm anteriorly, laterally and posteriorly 95% of PTV ...

A 61-year-old patient, initially presenting with urinary complaints, has undergone Stereotactic Body Radiation Therapy (SBRT) for prostate cancer at KMC Hospital Attavar Oncology Centre (KMCHAOC) in ...

In the new study, the researchers set out to confirm that PROSTOX works in a new group of 148 patients with prostate cancer receiving either MRI- or CT-guided SBRT from a phase III clinical trial at ...

to stereotactic body radiation therapy (SBRT) improves clinical progression-free survival in men with oligometastatic hormone-sensitive prostate cancer (mHSPC). In the phase 2 RADIOSA trial ...

SpaceOAR Hydrogel reduces radiation exposure to the rectum, minimizing bowel-related side effects in prostate cancer patients undergoing ... higher risk of bowel complications with stereotactic body ...